{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T05:21:36Z","timestamp":1733462496724,"version":"3.30.1"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Aortopathies can be congenital or acquired. Aortic atherosclerosis, abdominal aortic aneurysm, and degenerative aortic stenosis are some of the major manifestations of acquired aortopathy. Dyslipidemia, an imbalance of plasma lipid levels, is strongly associated with common aortopathies. A relationship between abdominal aortic aneurysm, degenerative aortic stenosis, and dyslipidemia has been identified in the literature but finding effective preventive strategies has been challenging. Nevertheless, lipid-lowering therapy remains a mainstay of both treatment and prevention. In patients with aortic atheroma, statins were found to be protective through the review of this study. There is currently no place for statins in the treatment or prevention of disease progression in patients with calcific aortic stenosis. Their low cost, widespread availability, and strong safety profile tip the risk-to-benefit ratio toward statins for abdominal aortic aneurysms but more research is needed. A review of proprotein convertase subtilisin\/kexin type 9 inhibitors may yield similar benefits for all aortopathy patients; however, those results are not yet available.<\/jats:p>","DOI":"10.1097\/crd.0000000000000586","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T13:00:12Z","timestamp":1690290012000},"page":"82-87","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Aortopathy: Effects of Lipid-Lowering Therapy"],"prefix":"10.1097","volume":"33","author":[{"given":"Matthew","family":"Vollaro","sequence":"first","affiliation":[{"name":"New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Sharma","sequence":"additional","affiliation":[{"name":"Departments of Cardiology and Medicine Westchester Medical Center and New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mala","family":"Sharma","sequence":"additional","affiliation":[{"name":"Departments of Cardiology and Medicine Westchester Medical Center and New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"Departments of Cardiology and Medicine Westchester Medical Center and New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[{"name":"Departments of Cardiology and Medicine Westchester Medical Center and New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,7,25]]},"reference":[{"key":"R1-20241205","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41569-020-00472-6","article-title":"Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes.","volume":"18","author":"Bossone","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"R2-20241205","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jacc.2013.05.015","article-title":"Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study.","volume":"62","author":"Osnabrugge","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R3-20241205","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: its etiology, effects and treatment.","volume":"176","author":"Yuan","year":"2007","journal-title":"CMAJ"},{"key":"R4-20241205","doi-asserted-by":"crossref","first-page":"891929","DOI":"10.3389\/fpubh.2022.891929","article-title":"The global burden of diseases attributed to high low-density lipoprotein cholesterol from 1990 to 2019.","volume":"10","author":"Zheng","year":"2022","journal-title":"Front Public Health"},{"key":"R5-20241205","first-page":"S139","article-title":"Epidemiology and management of hyperlipidemia.","volume":"23","author":"Karr","year":"2017","journal-title":"Am J Manag Care"},{"key":"R6-20241205","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/endrev\/bnab037","article-title":"A modern approach to dyslipidemia.","volume":"43","author":"Berberich","year":"2022","journal-title":"Endocr Rev"},{"key":"R7-20241205","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines.","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"R8-20241205","doi-asserted-by":"crossref","first-page":"17093","DOI":"10.1038\/nrdp.2017.93","article-title":"Familial hypercholesterolaemia.","volume":"3","author":"Defesche","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R9-20241205","first-page":"34369","article-title":"Pathophysiology and management of dyslipidaemia.","volume":"43","author":"Bereda","year":"2022","journal-title":"Biomed J Sci & Tech Res"},{"key":"R10-20241205","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study.","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R11-20241205","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0002-9149(97)89183-7","article-title":"Risk factors for new coronary events in a large cohort of very elderly patients with and without coronary artery disease.","volume":"77","author":"Aronow","year":"1996","journal-title":"Am J Cardiol"},{"key":"R13-20241205","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis.","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"key":"R14-20241205","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0002-9149(96)00214-7","article-title":"Risk factors for new atherothrombotic brain infarction in 664 older men and 1,488 older women.","volume":"77","author":"Aronow","year":"1996","journal-title":"Am J Cardiol"},{"key":"R15-20241205","first-page":"II2","article-title":"Inflammation as a cardiovascular risk factor.","volume":"109","author":"Willerson","year":"2004","journal-title":"Circulation"},{"key":"R16-20241205","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1194\/jlr.R800058-JLR200","article-title":"Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall.","volume":"50 Suppl","author":"Getz","year":"2009","journal-title":"J Lipid Res"},{"key":"R17-20241205","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. a consensus statement from the European Atherosclerosis Society consensus panel.","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"R18-20241205","doi-asserted-by":"crossref","first-page":"100336","DOI":"10.1016\/j.ajpc.2022.100336","article-title":"Lipid treatment status and goal attainment among patients with atherosclerotic cardiovascular disease in the United States: a 2019 update.","volume":"10","author":"Gu","year":"2022","journal-title":"Am J Prev Cardiol"},{"key":"R19-20241205","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.numecd.2015.02.001","article-title":"The lipid theory in the pathogenesis of calcific aortic stenosis.","volume":"25","author":"Parisi","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R20-20241205","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jacc.2005.09.049","article-title":"A high fat\/high carbohydrate diet induces aortic valve disease in C57BL\/6J mice.","volume":"47","author":"Drolet","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R21-20241205","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1161\/ATVBAHA.116.308147","article-title":"Lifetime risk and risk factors for abdominal aortic aneurysm in a 24-year prospective study: the ARIC study (atherosclerosis risk in communities).","volume":"36","author":"Tang","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R22-20241205","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jacc.2012.03.052","article-title":"Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy.","volume":"60","author":"Capoulade","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R23-20241205","doi-asserted-by":"crossref","first-page":"e0195719","DOI":"10.1371\/journal.pone.0195719","article-title":"Evaluation of the relationship between plasma lipids and abdominal aortic aneurysm: a mendelian randomization study.","volume":"13","author":"Weng","year":"2018","journal-title":"PLoS One"},{"key":"R24-20241205","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/medicina54020024","article-title":"Degenerative aortic stenosis, dyslipidemia and possibilities of medical treatment.","volume":"54","author":"Kleinauskien\u0117","year":"2018","journal-title":"Medicina (Kaunas)"},{"key":"R25-20241205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12964-019-0328-4","article-title":"Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer.","volume":"17","author":"Zhang","year":"2019","journal-title":"Cell Commun Signal"},{"key":"R26-20241205","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.chemphyslip.2016.05.003","article-title":"The role of cholesterol in membrane fusion.","volume":"199","author":"Yang","year":"2016","journal-title":"Chem Phys Lipids"},{"key":"R29-20241205","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1258\/acb.2011.011111","article-title":"Apolipoproteins: metabolic role and clinical biochemistry applications.","volume":"48","author":"Dominiczak","year":"2011","journal-title":"Ann Clin Biochem"},{"key":"R30-20241205","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0021-9150(75)90095-7","article-title":"The participation of aortic proteins in the formation of complexes between low density lipoproteins and intima-media extracts.","volume":"21","author":"Camejo","year":"1975","journal-title":"Atherosclerosis"},{"key":"R31-20241205","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nature00804","article-title":"Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.","volume":"417","author":"Sk\u00e5l\u00e9n","year":"2002","journal-title":"Nature"},{"key":"R32-20241205","first-page":"40","article-title":"Pathogenesis of atherosclerosis: a multifactorial process.","volume":"7","author":"Singh","year":"2002","journal-title":"Exp Clin Cardiol"},{"key":"R33-20241205","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1161\/CIRCULATIONAHA.105.537878","article-title":"Pathophysiology of coronary artery disease.","volume":"111","author":"Libby","year":"2005","journal-title":"Circulation"},{"key":"R34-20241205","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nm1099","article-title":"The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm.","volume":"10","author":"Zhao","year":"2004","journal-title":"Nat Med"},{"key":"R35-20241205","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III).","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"R36-20241205","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines.","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"R37-20241205","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.3390\/ijerph15122805","article-title":"Risk factors for abdominal aortic aneurysm in population-based studies: a systematic review and meta-analysis.","volume":"15","author":"Altobelli","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"R38-20241205","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/CIRCULATIONAHA.105.593418","article-title":"Aortic atherosclerotic disease and stroke.","volume":"114","author":"Kronzon","year":"2006","journal-title":"Circulation"},{"key":"R39-20241205","first-page":"160","article-title":"Exploring the relationship between hyperlipidemia and aortic stenosis.","volume":"3","author":"Weyman","year":"2002","journal-title":"Rev Cardiovasc Med"},{"key":"R40-20241205","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1161\/STROKEAHA.119.025813","article-title":"Aortic arch atherosclerosis in patients with embolic stroke of undetermined source: an exploratory analysis of the NAVIGATE ESUS Trial.","volume":"50","author":"Ntaios","year":"2019","journal-title":"Stroke"},{"key":"R41-20241205","first-page":"e16977","article-title":"Acute thromboembolic ischemic stroke from complex aortic arch plaque.","volume":"13","author":"Ali","year":"2021","journal-title":"Cureus"},{"key":"R42-20241205","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0735-1097(92)90139-E","article-title":"Protruding aortic atheromas predict stroke in elderly patients undergoing cardiopulmonary bypass: experience with intraoperative transesophageal echocardiography.","volume":"20","author":"Katz","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"R43-20241205","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.avsg.2017.10.006","article-title":"Elevated plasma levels of LDL cholesterol promote dissecting thoracic aortic aneurysms in angiotensin II-Induced mice.","volume":"48","author":"Tanaka","year":"2018","journal-title":"Ann Vasc Surg"},{"key":"R44-20241205","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.822515","article-title":"Hyperlipidemia and atherosclerosis.","volume":"193","author":"Ross","year":"1976","journal-title":"Science"},{"key":"R45-20241205","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/archinte.159.15.1793","article-title":"Clinical outcomes in statin treatment trials: a meta-analysis.","volume":"159","author":"Ross","year":"1999","journal-title":"Arch Intern Med"},{"key":"R46-20241205","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3400\/avd.oa.13-00065","article-title":"Statins reduce extensive aortic atheromas in patients with abdominal aortic aneurysms.","volume":"6","author":"Nemoto","year":"2013","journal-title":"Ann Vasc Dis"},{"key":"R47-20241205","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0002-9149(02)02870-9","article-title":"Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque.","volume":"90","author":"Tunick","year":"2002","journal-title":"Am J Cardiol"},{"key":"R48-20241205","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijcard.2015.05.001","article-title":"Effects of statin therapy on ascending aorta aneurysms growth: a propensity-matched analysis.","volume":"191","author":"Angeloni","year":"2015","journal-title":"Int J Cardiol"},{"key":"R49-20241205","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.jvs.2021.05.057","article-title":"Preoperative statin therapy is associated with higher 5-year survival after thoracic endovascular aortic repair.","volume":"74","author":"Allar","year":"2021","journal-title":"J Vasc Surg"},{"key":"R50-20241205","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.amjcard.2013.05.081","article-title":"Effect of statin drugs on thoracic aortic aneurysms.","volume":"112","author":"Stein","year":"2013","journal-title":"Am J Cardiol"},{"key":"R51-20241205","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1161\/ATVBAHA.114.304205","article-title":"Early development of calcific aortic valve disease and left ventricular hypertrophy in a mouse model of combined dyslipidemia and type 2 diabetes mellitus.","volume":"34","author":"Le Quang","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R52-20241205","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jacc.2006.07.072","article-title":"Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.","volume":"49","author":"Moura","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R53-20241205","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1093\/eurheartj\/ehaa1066","article-title":"Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia.","volume":"42","author":"P\u00e9rez de Isla","year":"2021","journal-title":"Eur Heart J"},{"key":"R54-20241205","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1210\/jc.2004-0432","article-title":"Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk.","volume":"89","author":"Carr","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R55-20241205","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/eurheartj\/ehx140","article-title":"Overall and abdominal obesity and incident aortic valve stenosis: two prospective cohort studies.","volume":"38","author":"Larsson","year":"2017","journal-title":"Eur Heart J"},{"key":"R56-20241205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1467-789X.2005.00165.x","article-title":"Prevalence of obesity in the United States.","volume":"6","author":"Baskin","year":"2005","journal-title":"Obes Rev"},{"key":"R57-20241205","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/01.mol.0000137229.00020.fe","article-title":"Hyperlipidaemia and aortic valve disease.","volume":"15","author":"Rosseb\u00f8","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"R58-20241205","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1093\/eurheartj\/ehaa070","article-title":"Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study.","volume":"41","author":"Nazarzadeh","year":"2020","journal-title":"Eur Heart J"},{"key":"R59-20241205","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/hrt.2004.036848","article-title":"Atherosclerosis-like lesions of the aortic valve are common in adults of all ages: a necropsy study.","volume":"91","author":"Kuusisto","year":"2005","journal-title":"Heart"},{"key":"R60-20241205","doi-asserted-by":"crossref","first-page":"667","DOI":"10.4330\/wjc.v9.i8.667","article-title":"Is there evidence for statins in the treatment of aortic valve stenosis?","volume":"9","author":"Akin","year":"2017","journal-title":"World J Cardiol"},{"key":"R61-20241205","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.amjcard.2006.10.064","article-title":"Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.","volume":"99","author":"Rosseb\u00f8","year":"2007","journal-title":"Am J Cardiol"},{"key":"R62-20241205","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.","volume":"359","author":"Rosseb\u00f8","year":"2008","journal-title":"N Engl J Med"},{"key":"R63-20241205","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.amjcard.2008.04.056","article-title":"Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis.","volume":"102","author":"Antonini-Canterin","year":"2008","journal-title":"Am J Cardiol"},{"key":"R64-20241205","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/hrt.2010.215046","article-title":"Do statins improve outcomes and delay the progression of non-rheumatic calcific aortic stenosis?","volume":"97","author":"Parolari","year":"2011","journal-title":"Heart"},{"key":"R65-20241205","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"R66-20241205","doi-asserted-by":"crossref","first-page":"901225","DOI":"10.3389\/fcvm.2022.901225","article-title":"Burden of aortic aneurysm and its attributable risk factors from 1990 to 2019: an analysis of the global burden of disease study 2019.","volume":"9","author":"Wang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R67-20241205","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1586\/14779072.2015.1074861","article-title":"Understanding the pathogenesis of abdominal aortic aneurysms.","volume":"13","author":"Kuivaniemi","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R68-20241205","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/j.jacc.2022.08.004","article-title":"2022 ACC\/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association\/American College of Cardiology joint Committee on Clinical Practice Guidelines.","volume":"80","author":"Isselbacher","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R69-20241205","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/SLA.0000000000002392","article-title":"Endovascular repair of abdominal aortic aneurysm in patients physically ineligible for open repair: very long-term follow-up in the EVAR-2 randomized controlled trial.","volume":"266","author":"Sweeting","year":"2017","journal-title":"Ann Surg"},{"key":"R70-20241205","first-page":"100836","article-title":"Systematic review and Meta-Analysis of Mendelian randomisation analyses of Abdominal aortic aneurysms.","volume":"35","author":"Ibrahim","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"R71-20241205","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.amjcard.2005.08.033","article-title":"Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins.","volume":"97","author":"Sukhija","year":"2006","journal-title":"Am J Cardiol"},{"key":"R72-20241205","first-page":"CD010447","article-title":"Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysm.","volume":"1","author":"Robertson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R73-20241205","doi-asserted-by":"crossref","first-page":"e008657","DOI":"10.1161\/JAHA.118.008657","article-title":"Statins reduce abdominal aortic aneurysm growth, rupture, and perioperative mortality: a systematic review and meta-analysis.","volume":"7","author":"Salata","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"R74-20241205","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jamacardio.2020.0728","article-title":"An Exploratory analysis of proprotein convertase subtilisin\/kexin type 9 inhibition and aortic stenosis in the FOURIER trial.","volume":"5","author":"Bergman","year":"2020","journal-title":"JAMA Cardiol"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T21:01:08Z","timestamp":1733432468000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000586","relation":{},"ISSN":["1538-4683"],"issn-type":[{"type":"electronic","value":"1538-4683"}],"subject":[],"published":{"date-parts":[[2023,7,25]]}}}